Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Hematology & Oncology Physician in Orange, CA
NPI: 1417273517Primary Practice Location
UNIVERSITY OF CALIFORNIA IRVINE MEDICAL CENTER
101 The City Dr S, Orange, CA
Primary Employer
UCI Department of Medicine
medschool.uci.edu
HQ Phone
Get M.D. Catherine's Phone Numberphone_androidMobile
Get M.D. Catherine's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License
CA State Medical License
CA State Medical License
2022 - 2026
NC State Medical License
2010 - 2023
NY State Medical License
2013 - 2017
American Board of Internal Medicine
Hematology
American Board of Internal Medicine
Medical Oncology
University Of Cincinnati College Of Medicine
med.uc.edu
Medical School
Until 2010
Memorial Sloan Kettering Cancer Center
Fellowship • Hematology and Medical Oncology
2013 - 2016
Duke University Hospital
Residency • Internal Medicine
2010 - 2013
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 52 | 336 |
| 2 | 99223Initial hospital inpatient care, typically 70 minutes per day | 32 | 35 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 20 | 34 |
| 4 | 99238Hospital discharge day management, 30 minutes or less | 18 | 20 |
| 5 | 99239Hospital discharge day management, more than 30 minutes | 15 | 16 |
Authors: Marc Hoffmann, John Byrd, Daniel Ermann, Paul Barr, Allison Winter, Christopher Jensen, Mazyar Shadman, Brian Koffman
Journal: Clin Lymphoma Myeloma Leuk
Publication Date: 2025-05-16
Cancer therapy shapes the fitness landscape of clonal hematopoiesis.
Authors: Zsofia Stadler, Barbara Spitzer, Larry Norton, Christopher Gibson, Simon Mantha, Benjamin Ebert, Todd Druley, Howard Scher, Mark Robson, Martin Tallman, Eric Padron, David Hyman, Lior Braunstein, Dean Bajorin, Daniel Kelly
Journal: Nat Genet
Publication Date: 2020-10-26
Philadelphia Chromosome-positive Acute Myeloid Leukemia With e1a3 BCR-ABL1 Fusion Transcript.
Authors: Julia Sheets, Patrick Eulitt, Matthew Foster
Journal: Hemasphere
Publication Date: 2020-10-14
Lead Sponsor: UNC Lineberger Comprehensive Cancer Center
Intervention / Treatment: DRUG: Bendamustine, DRUG: Cyclophosphamide, DRUG: Fludarabine, BIOLOGICAL: ATLCAR.CD30 T cells
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Bone Marrow Biopsy, DRUG: Venetoclax, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, DRUG: Ibrutinib, PROCEDURE: Computed Tomography, BIOLOGICAL: Obinutuzumab
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Venetoclax, DRUG: Ibrutinib, BIOLOGICAL: Obinutuzumab, OTHER: Observation Activity
